Glimepiride: Sulfonylurea, Gastrointestinal tract, Anti-diabetic drug, Diabetes mellitus type 2, Secretagogue, Sanofi-Aventis - Tapa blanda

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic drug. It is marketed as Amaryl by Sanofi- Aventis and Glista OD by Cadila Pharmaceuticals Ltd. Glimepiride is the first third-generation sulfonylurea, and is very potent. It is sometimes classified as third-generation, and sometimes classified as second- generation.